Literature DB >> 32513346

Evaluation of modelling study shows limits of COVID-19 importing risk simulations in sub-Saharan Africa.

T Miyachi1, T Tanimoto1, M Kami1.   

Abstract

Mathematical modelling studies predicting the spread of the coronavirus disease 2019 (COVID-19) have been used worldwide, but precisions are limited. Thus, continuous evaluation of the modelling studies is crucial. We investigated situations of virus importation in sub-Saharan Africa (SSA) to assess effectiveness of a modelling study by Haider N et al. titled 'Passengers' destinations from China: low risk of novel coronavirus (2019-nCoV) transmission into Africa and South America'. We obtained epidemiological data of 2417 COVID-19 cases reported by 40 countries in SSA within 30 days of the first case confirmed in Nigeria on 27 February. Out of 442 cases which had travel history available, only one (0.2%) had a travel history to China. These findings underline the result of the model. However, the fact that there were numbers of imported cases from other regions shows the limits of the model. The limits could be attributed to the characteristics of the COVID-19 which is infectious even when the patients do not express any symptoms. Therefore, there is a profound need for all modelling researchers to take asymptomatic cases into account when they establish modelling studies.

Entities:  

Keywords:  COVID-19; mathematical modelling

Mesh:

Year:  2020        PMID: 32513346      PMCID: PMC7303472          DOI: 10.1017/S095026882000120X

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


To the Editor-in-Chief: The recently published article of Haider N et al., titled ‘Passengers’ destinations from China: low risk of novel coronavirus (2019-nCoV) transmission into Africa and South America’ is of great help for international organisations and national health authorities to improve preventative measurements against the virus importation. Haider N et al. concluded that risk of the virus importation in Africa was relatively low except South Africa, Ethiopia and Mauritius based on direct flights from four major cities of China (Wuhan, Beijing, Shanghai and Guangzhou) to the passengers' destination countries [1]. Considering the current situation, we would like to discuss more on their implications but also the challenges and effectiveness of modelling studies predicting the spread of the virus. Since the COVID-19 emerged in China, mathematical modelling studies have been used worldwide. These help guide governments to form public health strategies. However, precisions are limited because they simplify complex social characteristics [2]. Few analyses were carried out to evaluate modelling studies. In sub-Saharan Africa (SSA), precise models are particularly important to enhance their public health measurements and minimise the economic damage since their resources to combat diseases are already overwhelmed [3]. Thus, we investigated situations of virus importation in SSA to assess effectiveness of a modelling study on global transmission of COVID-19 by Haider N et al. We obtained epidemiological data of 2417 COVID-19 cases reported by 40 countries in SSA within the 30 days of the first case confirmed in Nigeria on 27 February 2020 [4]. Out of 442 cases which had travel history available, Europe was the highest, 292 cases (66.1%), followed by Middle East 71 (16%), North America 32 (7.2%), Africa 28 (6.3%), Asia 16 (3.6%) and others 3 (0.6%).Concerning Asia, only one had a travel history to China, which was reported in Somalia on 16 March 2020. These results partially supported the modelling study since there was only one case from China in SSA. However, the fact that there were numbers of imported cases from other regions shows the limits of the model. The limits could be attributed to the characteristics of the COVID-19, which is infectious even when the patients do not express any symptoms [5]. Undetected cases might have already spread across the world by the time importation risk of COVID-19 from China was simulated. Consequently, there is a profound need for all modelling researchers to take asymptomatic cases into account when they establish modelling studies. Our study involving countries lacking some data is too small and too insufficient to make a definite conclusion. Further studies are warranted.
  4 in total

1.  Special report: The simulations driving the world's response to COVID-19.

Authors:  David Adam
Journal:  Nature       Date:  2020-04       Impact factor: 49.962

2.  Africa in the Path of Covid-19.

Authors:  Wafaa M El-Sadr; Jessica Justman
Journal:  N Engl J Med       Date:  2020-04-17       Impact factor: 91.245

3.  Asymptomatic Transmission, the Achilles' Heel of Current Strategies to Control Covid-19.

Authors:  Monica Gandhi; Deborah S Yokoe; Diane V Havlir
Journal:  N Engl J Med       Date:  2020-04-24       Impact factor: 91.245

4.  Passengers' destinations from China: low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South America.

Authors:  Najmul Haider; Alexei Yavlinsky; David Simons; Abdinasir Yusuf Osman; Francine Ntoumi; Alimuddin Zumla; Richard Kock
Journal:  Epidemiol Infect       Date:  2020-02-26       Impact factor: 2.451

  4 in total
  3 in total

1.  Mathematical modelling of the epidemiology of COVID-19 infection in Ghana.

Authors:  Benedict Barnes; Joseph Ackora-Prah; Francis Ohene Boateng; Leticia Amanor
Journal:  Sci Afr       Date:  2021-12-18

2.  Response to 'Evaluation of modelling study shows limits of COVID-19 importing risk simulations in sub-Saharan Africa' (Epidemiology and Infection - HYG-LE-10513-May-20).

Authors:  Najmul Haider; Alexei Yavlinsky; Richard Kock
Journal:  Epidemiol Infect       Date:  2020-06-10       Impact factor: 2.451

Review 3.  Lockdown measures in response to COVID-19 in nine sub-Saharan African countries.

Authors:  Najmul Haider; Abdinasir Yusuf Osman; Audrey Gadzekpo; George O Akipede; Danny Asogun; Rashid Ansumana; Richard John Lessells; Palwasha Khan; Muzamil Mahdi Abdel Hamid; Dorothy Yeboah-Manu; Leonard Mboera; Elizabeth Henry Shayo; Blandina T Mmbaga; Mark Urassa; David Musoke; Nathan Kapata; Rashida Abbas Ferrand; Pascalina-Chanda Kapata; Florian Stigler; Thomas Czypionka; Alimuddin Zumla; Richard Kock; David McCoy
Journal:  BMJ Glob Health       Date:  2020-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.